BCTX
BriaCell Therapeutics Corp
3월 13일 4:00 PM ET (한국 3/14 05:00)
$4.22
-0.08 ▼ -1.86%
🌙 3월 13일 7:38 PM ET (한국 3/14 08:38)
$4.29
+0.07 ▲ +1.66%
| Index | - | P/E | - | EPS (ttm) | -27.63 | Insider Own | 1.55% | Shs Outstand | 0.01B | Perf Week | 9.33% |
| Market Cap | 0.03B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 0.01B | Perf Month | 0.24% |
| Enterprise Value | -0.00B | PEG | - | EPS next Q | - | Inst Own | 10.28% | Short Float | 1.46% | Perf Quarter | -62.69% |
| Income | -0.03B | P/S | - | EPS this Y | - | Inst Trans | 0.24% | Short Ratio | 0.22 | Perf Half Y | -48.09% |
| Sales | 0.00B | P/B | 0.99 | EPS next 5Y | - | ROA | -137.98% | Short Interest | 0.10M | Perf YTD | -40.65% |
| Book/sh | 4.26 | P/C | 1.02 | EPS past 3/5Y | 37.91% 39.57% | ROE | -171.72% | 52W High | -95.7% ($98.20) | Perf Year | -87.77% |
| Cash/sh | 4.12 | P/FCF | - | Sales past 3/5Y | - | ROIC | -95.86% | 52W Low | 17.22% ($3.60) | Perf 3Y | -99.59% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 44.72% | Gross Margin | - | Volatility(W/M) | 8.73% 7.7% | Perf 5Y | -99.25% |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.37 | Perf 10Y | -99.93% |
| Dividend Ex-Date | - | Quick Ratio | 10.1 | EPS Q/Q | 88.94% | Profit Margin | - | RSI (14) | 48.6 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 10.1 | Sales Q/Q | - | SMA20 | 5.98% ($3.98) | Beta | 1.34 | Target Price | $150 |
| Payout | - | Debt/Eq | 0 | Earnings | 3000000 | SMA50 | -12.42% ($4.82) | Rel Volume | 0.76 | Prev Close | $4.3 |
| Employees | 17 | LT Debt/Eq | 0 | EPS/Sales Surpr. | - | SMA200 | -63.67% ($11.62) | Avg Volume(3M) | 0.47M | Price | $4.22 |
| IPO | 2010/10/28 | Option/Short | No/Yes | Trades | 1044 | Volume | 360,610 | Change | -1.86% |
뉴스 로딩 중...